Literature DB >> 15725583

The frequency of limb girdle muscular dystrophy 2A in northeastern Italy.

Marina Fanin1, Anna Chiara Nascimbeni, Luigi Fulizio, Corrado Angelini.   

Abstract

Limb-girdle muscular dystrophy 2A (LGMD2A) is considered to be the most frequent LGMD. Our study surveyed an area in northeastern Italy where an almost complete ascertainment was possible. To identify LGMD2A patients we used a new diagnostic approach, including several molecular and biochemical methods. In 84 screened patients from northeastern Italy, we identified 39 LGMD2A patients, the prevalence of LGMD2A being 9.47 per million. In the Venezia district it appears higher than in other districts of the Veneto region, and in the Friuli region it is three times higher than in Veneto, due to the recurrence of single mutation. Haplotype analysis suggested a founder effect. The population from Venezia and Friuli has a higher risk of being heterozygote for these two mutant alleles than people from the rest of northeastern Italy. Our results indicate that LGMD2A is one of the most frequent autosomal recessive disorders, thus finding its molecular characterization becoming increasingly important.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15725583     DOI: 10.1016/j.nmd.2004.11.003

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  29 in total

1.  Molecular Diagnosis of Limb-girdle Muscular Dystrophy Type 2A by Next-generation Sequencing.

Authors:  Clara Gómez-González; Maria Isabel Esteban-Rodríguez; Yolanda Ruano; Elena Vallespín; Pablo Lapunzina; Paloma Martínez; Samuel I Pascual; Jesús Molano; Carmen Prior
Journal:  Ann Indian Acad Neurol       Date:  2017 Apr-Jun       Impact factor: 1.383

2.  European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A).

Authors:  Andrea Barp; Pascal Laforet; Luca Bello; Giorgio Tasca; John Vissing; Mauro Monforte; Enzo Ricci; Ariane Choumert; Tanya Stojkovic; Edoardo Malfatti; Elena Pegoraro; Claudio Semplicini; Roberto Stramare; Olivier Scheidegger; Jana Haberlova; Volker Straub; Chiara Marini-Bettolo; Nicoline Løkken; Jordi Diaz-Manera; Jon A Urtizberea; Eugenio Mercuri; Martin Kynčl; Maggie C Walter; Robert Y Carlier
Journal:  J Neurol       Date:  2019-09-25       Impact factor: 4.849

3.  Titin splicing regulates cardiotoxicity associated with calpain 3 gene therapy for limb-girdle muscular dystrophy type 2A.

Authors:  William Lostal; Carinne Roudaut; Marine Faivre; Karine Charton; Laurence Suel; Nathalie Bourg; Heather Best; John Edward Smith; Jochen Gohlke; Guillaume Corre; Xidan Li; Zaher Elbeck; Ralph Knöll; Jack-Yves Deschamps; Henk Granzier; Isabelle Richard
Journal:  Sci Transl Med       Date:  2019-11-27       Impact factor: 17.956

4.  Mitochondrial abnormalities, energy deficit and oxidative stress are features of calpain 3 deficiency in skeletal muscle.

Authors:  Irina Kramerova; Elena Kudryashova; Benjamin Wu; Sean Germain; Krista Vandenborne; Nadine Romain; Ronald G Haller; M Anthony Verity; Melissa J Spencer
Journal:  Hum Mol Genet       Date:  2009-05-29       Impact factor: 6.150

5.  Impaired regeneration in LGMD2A supported by increased PAX7-positive satellite cell content and muscle-specific microrna dysregulation.

Authors:  Xiomara Q Rosales; Vinod Malik; Amita Sneh; Lei Chen; Sarah Lewis; Janaiah Kota; Julie M Gastier-Foster; Caroline Astbury; Rob Pyatt; Shalini Reshmi; Louise R Rodino-Klapac; K Reed Clark; Jerry R Mendell; Zarife Sahenk
Journal:  Muscle Nerve       Date:  2013-03-29       Impact factor: 3.217

Review 6.  Limb-girdle muscular dystrophies - international collaborations for translational research.

Authors:  Rachel Thompson; Volker Straub
Journal:  Nat Rev Neurol       Date:  2016-04-01       Impact factor: 42.937

Review 7.  Calpain 3, the "gatekeeper" of proper sarcomere assembly, turnover and maintenance.

Authors:  Jacques S Beckmann; Melissa Spencer
Journal:  Neuromuscul Disord       Date:  2008-10-29       Impact factor: 4.296

8.  Novel Missense CAPN3 Mutation Responsible for Adult-Onset Limb Girdle Muscular Dystrophy with Calves Hypertrophy.

Authors:  Sabrine Rekik; Salma Sakka; Sawssan Ben Romdhan; Nouha Farhat; Yasmine Baba Amer; Leila Lehkim; François Jérôme Authier; Chokri Mhiri
Journal:  J Mol Neurosci       Date:  2019-08-13       Impact factor: 3.444

9.  Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population.

Authors:  Fiona L M Norwood; Chris Harling; Patrick F Chinnery; Michelle Eagle; Kate Bushby; Volker Straub
Journal:  Brain       Date:  2009-09-18       Impact factor: 13.501

10.  How to tackle the diagnosis of limb-girdle muscular dystrophy 2A.

Authors:  Marina Fanin; Anna Chiara Nascimbeni; Elisabetta Tasca; Corrado Angelini
Journal:  Eur J Hum Genet       Date:  2008-10-15       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.